Exact Imaging Technology Featured in JAMA – Micro-Ultrasound Demonstrated Noninferior to MRI in Prostate Cancer Detection

We are proud to share a significant milestone for our portfolio company, Exact Imaging – the company’s micro-ultrasound technology has been featured in a landmark JAMA-published clinical trial.

Source: JAMA LinkedIn

The OPTIMUM randomized trial, spanning 678 biopsy-naive men across 20 centers (8 countries), found that micro-ultrasound–guided biopsy was noninferior to conventional MRI fusion–guided biopsy in detecting clinically significant prostate cancer (Gleason Grade Group ≥2). This positions micro-ultrasound as a compelling, accessible alternative to MRI for image-guided prostate biopsy—especially in frontline settings where MRI access remains limited.

Publication in JAMA—one of the world’s most influential medical journals—not only validates Exact Imaging’s innovation, but reinforces the growing clinical momentum behind their platform. We’re proud to back a team driving global change in prostate cancer diagnostics.

[Read the full study here → https://jamanetwork.com/journals/jama/article-abstract/2831985]